Amgen, Inc. (AMGN)
403.04
-4.23
(-1.04%)
USD |
NASDAQ |
Oct 02, 16:00
403.83
+0.79
(+0.20%)
After-Hours: 20:00
Amgen Gross Profit Margin (Quarterly) : 72.08% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.08% |
| March 31, 2026 | 68.29% |
| December 31, 2025 | 81.91% |
| September 30, 2025 | 67.85% |
| June 30, 2025 | 67.15% |
| March 31, 2025 | 63.33% |
| December 31, 2024 | 83.02% |
| September 30, 2024 | 60.87% |
| June 30, 2024 | 61.17% |
| March 31, 2024 | 56.73% |
| December 31, 2023 | 61.75% |
| September 30, 2023 | 73.71% |
| June 30, 2023 | 73.91% |
| March 31, 2023 | 71.58% |
| December 31, 2022 | 74.15% |
| September 30, 2022 | 75.88% |
| June 30, 2022 | 76.91% |
| March 31, 2022 | 74.87% |
| December 31, 2021 | 74.85% |
| September 30, 2021 | 76.02% |
| June 30, 2021 | 74.98% |
| March 31, 2021 | 74.75% |
| December 31, 2020 | 75.85% |
| September 30, 2020 | 75.54% |
| June 30, 2020 | 75.76% |
| Date | Value |
|---|---|
| March 31, 2020 | 75.25% |
| December 31, 2019 | 79.65% |
| September 30, 2019 | 81.86% |
| June 30, 2019 | 82.70% |
| March 31, 2019 | 80.97% |
| December 31, 2018 | 82.32% |
| September 30, 2018 | 82.43% |
| June 30, 2018 | 83.16% |
| March 31, 2018 | 83.11% |
| December 31, 2017 | 81.82% |
| September 30, 2017 | 82.86% |
| June 30, 2017 | 82.27% |
| March 31, 2017 | 81.58% |
| December 31, 2016 | 81.91% |
| September 30, 2016 | 82.12% |
| June 30, 2016 | 81.28% |
| March 31, 2016 | 81.26% |
| December 31, 2015 | 80.55% |
| September 30, 2015 | 81.89% |
| June 30, 2015 | 79.66% |
| March 31, 2015 | 81.47% |
| December 31, 2014 | 79.14% |
| September 30, 2014 | 79.31% |
| June 30, 2014 | 79.13% |
| March 31, 2014 | 78.08% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 79.81% |
| Regeneron Pharmaceuticals, Inc. | 83.68% |
| AbbVie, Inc. | 74.71% |
| Biogen, Inc. | 61.37% |
| Vertex Pharmaceuticals, Inc. | 85.37% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 93.84% |
| Return on Assets | 9.57% |
| Return on Invested Capital | 13.35% |
| Profit Margin (Quarterly) | 23.59% |
| Operating Margin (Quarterly) | 35.04% |
| Return on Net Operating Assets | 13.44% |